Advocacy at a Glance 4/19/13 Advocacy at a Glance 4/19/13 Alliance Sets FY 14 Budget Recommendation for FDA Funding and more Read More Uncategorized 4/12/13 Uncategorized 4/12/13 Interpreting the President's FY 14 Budget for FDA Read More Advocacy at a Glance 4/12/13 Advocacy at a Glance 4/12/13 Alliance Meeting with our Appropriations Subcommittee Chairmen and more Read More Uncategorized 4/10/13 Uncategorized 4/10/13 Initial Alliance Comment on President's Request for FDA for FY 14 Read More Uncategorized 4/5/13 Uncategorized 4/5/13 Additional Q&As re FDA Funding and FY 13 Appropriations Law Read More Advocacy at a Glance 4/5/13 Advocacy at a Glance 4/5/13 Senate Agriculture FDA Appropriations Subcommittee Testimony on FY 2014 Due April 26th and more Read More Uncategorized 3/29/13 Uncategorized 3/29/13 BA Monies, User Fees, and Related Complications for FY 13 Read More Uncategorized 3/29/13 Uncategorized 3/29/13 Consolidated and Further Continuing Appropriations Act of 2013 and more Read More Uncategorized 3/22/13 Uncategorized 3/22/13 Understanding the FY13 Full-Year Continuing Resolution Bill Read More Advocacy at a Glance 3/22/13 Advocacy at a Glance 3/22/13 On FY 13 Appropriations and more Read More Uncategorized 3/21/13 Uncategorized 3/21/13 FDA Does Well as House, Senate Pass FY13 CR Read More Uncategorized 3/15/13 Uncategorized 3/15/13 One Key Issue; Two Different Perspectives Read More Advocacy at a Glance 3/15/13 Advocacy at a Glance 3/15/13 Stronger FDA Hill Day This Tuesday, March 19th and more Read More Uncategorized 3/13/13 Uncategorized 3/13/13 FY13 Appropriations Proposed by Senate Appropriations Committee Read More Uncategorized 3/9/13 Uncategorized 3/9/13 Sequester Update and House Extension of CR Read More Advocacy at a Glance 3/9/13 Advocacy at a Glance 3/9/13 Alliance for a Stronger FDA Hill Day, Tuesday, March 19th and more Read More Analysis and Commentary 3/1/13 Analysis and Commentary 3/1/13 And So It Begins ... Read More Advocacy at a Glance 3/1/13 Advocacy at a Glance 3/1/13 Alliance President Diane Dorman Expresses Concern on Inadequate FDA Funding and more Read More Uncategorized 2/27/13 Uncategorized 2/27/13 FDA Funding Situation Puts Agency Mission "At Risk," Says Alliance President Read More Uncategorized 2/25/13 Uncategorized 2/25/13 The Importance of the Alliance's Mission Read More Newer Posts Older Posts
Advocacy at a Glance 4/19/13 Advocacy at a Glance 4/19/13 Alliance Sets FY 14 Budget Recommendation for FDA Funding and more Read More
Uncategorized 4/12/13 Uncategorized 4/12/13 Interpreting the President's FY 14 Budget for FDA Read More
Advocacy at a Glance 4/12/13 Advocacy at a Glance 4/12/13 Alliance Meeting with our Appropriations Subcommittee Chairmen and more Read More
Uncategorized 4/10/13 Uncategorized 4/10/13 Initial Alliance Comment on President's Request for FDA for FY 14 Read More
Uncategorized 4/5/13 Uncategorized 4/5/13 Additional Q&As re FDA Funding and FY 13 Appropriations Law Read More
Advocacy at a Glance 4/5/13 Advocacy at a Glance 4/5/13 Senate Agriculture FDA Appropriations Subcommittee Testimony on FY 2014 Due April 26th and more Read More
Uncategorized 3/29/13 Uncategorized 3/29/13 BA Monies, User Fees, and Related Complications for FY 13 Read More
Uncategorized 3/29/13 Uncategorized 3/29/13 Consolidated and Further Continuing Appropriations Act of 2013 and more Read More
Uncategorized 3/22/13 Uncategorized 3/22/13 Understanding the FY13 Full-Year Continuing Resolution Bill Read More
Advocacy at a Glance 3/15/13 Advocacy at a Glance 3/15/13 Stronger FDA Hill Day This Tuesday, March 19th and more Read More
Uncategorized 3/13/13 Uncategorized 3/13/13 FY13 Appropriations Proposed by Senate Appropriations Committee Read More
Advocacy at a Glance 3/9/13 Advocacy at a Glance 3/9/13 Alliance for a Stronger FDA Hill Day, Tuesday, March 19th and more Read More
Advocacy at a Glance 3/1/13 Advocacy at a Glance 3/1/13 Alliance President Diane Dorman Expresses Concern on Inadequate FDA Funding and more Read More
Uncategorized 2/27/13 Uncategorized 2/27/13 FDA Funding Situation Puts Agency Mission "At Risk," Says Alliance President Read More
